secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001722482-24-000084
Event type: debt
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor refinances $772M term loans at lower rate; former EVP to advise
-----------------------------------------------------------------------

- Refinanced $772.4M Incremental B-6 Dollar Term Loans at SOFR + 2.00% (down from +2.25% on prior loans).
- New loans mature Nov 6, 2027, same maturity as refinanced B-5 loans; proceeds used to repay existing B-5 term loans.
- Dr. Gerard Brophy, former EVP Biopharma Production, gets consulting deals: $180K/yr cash + $25K/yr + $50K RSU for SAB chair role through Feb 2027.
- Consulting agreements include noncompetition, nonsolicitation, and IP assignment provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/0001722482-24-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/avtr-20240402.htm
  HTML page:      https://secwatch.observer/filing/0001722482-24-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer